190 likes | 471 Views
Start. Basic Characterization. Exposure Assessment. Unacceptable. Acceptable. Uncertain. Control Measures. Further Information Gathering. Periodic Re-Assessment. A Strategy for Assessing and Managing Occupational Exposures.
E N D
Start Basic Characterization Exposure Assessment Unacceptable Acceptable Uncertain Control Measures Further Information Gathering Periodic Re-Assessment A Strategy for Assessing and Managing Occupational Exposures
How do we develop the comprehensive metrology, instrumentation, and standards to support a nanotechnology ESH program?
Control Approach • General Ventilation • Engineering Control • Containment • Specialist Advice Exposure ManagementControl banding - concept Parameters Amount Used Dustiness Hazard Group (R-Phrase) www.ilo.org NIOSH: TJ Lentz
A requirement from the U.K. Regulationson Control of Substances Hazardous to Health (COSHH) COSHH requires you to carry out health surveillance in the following circumstances: • where employees are exposed to a substance linked to a particular disease or adverse health effect • and there is a reasonable likelihood, under the conditions of the work, of that disease or effect occurring • and it is possible to detect the disease or health effect. Reference: COSHH: A brief guide to the Regulations What you need to know about the Control of Substances Hazardous to Health Regulations 2002 (COSHH), Health and safety Executive, INDG136rev3 04/05 C2000 (April 2005).
Comprehensive Industrial Hygiene Program Functional Elements Hazardous Materials Management Hearing Conservation Exposure Monitoring Engineering Controls Hazard Communication Exposure Assessment Personal Protective Equipment Epidemiology Studies Medical Surveillance
G. Heterogeneous agglomerate A. Spherical homogeneous D. Agglomerate homogeneous B. Fibrous homogeneous E. Heterogeneous concentric H. Active particle F. Heterogeneous distributed C. Non-spherical homogeneous I. Multifunctional particle Particle CategoriesClasses of engineered nanoparticles (not necessarily inclusive) Dr. Andrew D. Maynard: Woodrow Wilson International Center for Scholars
A. Spherical homogeneous Particle CategoriesClasses of engineered nanoparticles (not necessarily inclusive) Dr. Andrew D. Maynard: Woodrow Wilson International Center for Scholars
B. Fibrous homogeneous Particle CategoriesClasses of engineered nanoparticles (not necessarily inclusive) Dr. Andrew D. Maynard: Woodrow Wilson International Center for Scholars
C. Non-spherical homogeneous Particle CategoriesClasses of engineered nanoparticles (not necessarily inclusive) Dr. Andrew D. Maynard: Woodrow Wilson International Center for Scholars
D. Agglomerate homogeneous Particle CategoriesClasses of engineered nanoparticles (not necessarily inclusive) Dr. Andrew D. Maynard: Woodrow Wilson International Center for Scholars
Particle CategoriesClasses of engineered nanoparticles E. Heterogeneous concentric (not necessarily inclusive) Dr. Andrew D. Maynard: Woodrow Wilson International Center for Scholars
F. Heterogeneous distributed Particle CategoriesClasses of engineered nanoparticles (not necessarily inclusive) Dr. Andrew D. Maynard: Woodrow Wilson International Center for Scholars
G. Heterogeneous agglomerate Particle CategoriesClasses of engineered nanoparticles (not necessarily inclusive) Dr. Andrew D. Maynard: Woodrow Wilson International Center for Scholars
H. Active particle Particle CategoriesClasses of engineered nanoparticles (not necessarily inclusive) Dr. Andrew D. Maynard: Woodrow Wilson International Center for Scholars
Particle CategoriesClasses of engineered nanoparticles I. Multifunctional particle (not necessarily inclusive) Dr. Andrew D. Maynard: Woodrow Wilson International Center for Scholars
G. Heterogeneous agglomerate A. Spherical homogeneous D. Agglomerate homogeneous B. Fibrous homogeneous E. Heterogeneous concentric H. Active particle F. Heterogeneous distributed C. Non-spherical homogeneous I. Multifunctional particle Particle CategoriesClasses of engineered nanoparticles (not necessarily inclusive) Dr. Andrew D. Maynard: Woodrow Wilson International Center for Scholars
Approaches to Safe Nanotechnology is a dynamic document about which NIOSH seeks public input, and that NIOSH will periodically update. • Developing a comprehensive, centralized information management system across agencies and organizations would be a significant contribution www.cdc.gov/niosh/topics/nanotech
The findings and conclusions of this presentation have not been formallydisseminated by the National Institute for Occupational Safety and Heathand should not be construed to represent any agency determination or policy. Mention of company or product does not constitute endorsement by the Centers for Disease Control and Prevention or the National Institute for Occupational Safety and Health. The assistance of many colleagues in the NIOSH Nanotechnology ResearchProgram and our partnering organizations is gratefully acknowledged. Mark.Hoover@cdc.hhs.gov 304-285-6374 Vladimir.Murashov@cdc.hhs.gov 202-401-3737